Clinical Trial Update: Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial (AXIOM) sponsored by the National Cancer Institute evaluating atezolizumab plus selinexor for alveolar soft part sarcoma and so…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Tecentriq (atezolizumab)
• XPOVIO (selinexor)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING